Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016

X Yao, ND Shah, BJ Gersh, F Lopez-Jimenez… - JAMA Network …, 2020 - jamanetwork.com
Importance Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in the US,
with studies indicating substantial rates of nonadherence to and undertreatment with statin …

High-intensity statin use among patients with atherosclerosis in the US

AJ Nelson, K Haynes, S Shambhu, Z Eapen… - Journal of the American …, 2022 - jacc.org
Background Preventive therapy among patients with established atherosclerotic
cardiovascular disease (ASCVD) is generally underused. Whether new guideline …

Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat

MB Mortensen, BG Nordestgaard - JAMA cardiology, 2019 - jamanetwork.com
Importance Five major guidelines on statin use for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) have been published since 2014: the National Institute for …

Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition …

MD Chobufo, SR Regner, I Zeb… - European journal of …, 2022 - academic.oup.com
Aims To assess the current state of statin use, factors associated with non-use, and estimate
the burden of potentially preventable atherosclerotic cardiovascular diseases (ASCVD) …

Primary prevention with statins: ACC/AHA risk-based approach versus trial-based approaches to guide statin therapy

MB Mortensen, S Afzal, BG Nordestgaard… - Journal of the American …, 2015 - jacc.org
Background: Guidelines recommend initiating primary prevention for atherosclerotic
cardiovascular disease (ASCVD) with statins based on absolute ASCVD risk assessment …

Comparison of recommended eligibility for primary prevention statin therapy based on the US Preventive Services Task Force recommendations vs the ACC/AHA …

NJ Pagidipati, AM Navar, H Mulder, AD Sniderman… - Jama, 2017 - jamanetwork.com
Importance There are important differences among guideline recommendations for using
statin therapy in primary prevention. New recommendations from the US Preventive …

Statin therapy for the primary prevention of cardiovascular disease: Pros

AC Razavi, A Mehta, LS Sperling - Atherosclerosis, 2022 - Elsevier
The initiation of statins for the primary prevention of atherosclerotic cardiovascular disease
(ASCVD) remains a debated subject, despite decades worth of clinical trial data …

Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement

CM Mangione, MJ Barry, WK Nicholson, M Cabana… - Jama, 2022 - jamanetwork.com
Importance Cardiovascular disease (CVD) is the leading cause of morbidity and death in the
US and is the cause of more than 1 of every 4 deaths. Coronary heart disease is the single …

Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease

F Rodriguez, DJ Maron, JW Knowles, SS Virani… - JAMA …, 2017 - jamanetwork.com
Importance High-intensity statin therapy is recommended for the secondary prevention of
atherosclerotic cardiovascular disease (ASCVD). Nevertheless, statin therapy in general …

Gaps in guideline-based lipid-lowering therapy for secondary prevention in the United States: a retrospective cohort study of 322 153 patients

AM Navar, AA Kolkailah, A Gupta… - … Quality and Outcomes, 2023 - Am Heart Assoc
BACKGROUND: Many patients with atherosclerotic cardiovascular disease (ASCVD) are not
on guideline-recommended statin therapy. We evaluated utilization of statins and other lipid …